IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-60421-0.html
   My bibliography  Save this article

A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer

Author

Listed:
  • Erika Zuljan

    (Berlin Institute of Health at Charité–Universitätsmedizin Berlin)

  • Benjamin Emde

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin)

  • Iris Piwonski

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin)

  • Ana Pestana

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin)

  • Konrad Klinghammer

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    BIH and MDC)

  • Andreas Mock

    (core center Heidelberg
    Ludwig-Maximilians-University Munich
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital)

  • Peter Horak

    (core center Heidelberg
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital)

  • Christoph Heining

    (and Helmholtz-Zentrum Dresden - Rossendorf (HZDR)
    TUD Dresden University of Technology
    partner site Dresden)

  • Frederick Klauschen

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    Ludwig-Maximilians-University Munich
    partner site Munich)

  • Ina Pretzell

    (West German Cancer Center
    partner site Essen)

  • Melanie Boerries

    (University of Freiburg
    a partnership between DKFZ and Medical Center - University of Freiburg)

  • Christian H. Brandts

    (Hematology/Oncology & University Cancer Center Frankfurt (UCT)
    partner site Frankfurt)

  • Simon Kreutzfeldt

    (core center Heidelberg
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital)

  • Maria-Veronica Teleanu

    (core center Heidelberg
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital)

  • Daniel Hübschmann

    (core center Heidelberg
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital)

  • Luc G. T. Morris

    (Memorial Sloan Kettering Cancer Center)

  • Max Heiland

    (BIH and MDC
    Humboldt-Universität zu Berlin)

  • Ulrich Keller

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    BIH and MDC)

  • Thomas Conrad

    (Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association)

  • Hanno Glimm

    (and Helmholtz-Zentrum Dresden - Rossendorf (HZDR)
    TUD Dresden University of Technology
    partner site Dresden)

  • Stefan Fröhling

    (core center Heidelberg
    German Cancer Research Center (DKFZ)
    a partnership between DKFZ and Heidelberg University Hospital
    Heidelberg University)

  • Sebastian Ochsenreither

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    BIH and MDC)

  • Ulrich Keilholz

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    BIH and MDC)

  • Eric Blanc

    (Berlin Institute of Health at Charité–Universitätsmedizin Berlin)

  • Dieter Beule

    (Berlin Institute of Health at Charité–Universitätsmedizin Berlin)

  • Damian T. Rieke

    (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    a partnership between DKFZ and Charité - Universitätsmedizin Berlin
    BIH and MDC)

Abstract

Salivary gland cancers are rare, diverse malignancies characterized by poor response to immunotherapy. The tumor immune environment in these cancers remains poorly understood. To address this, we perform an integrative analysis of the tumor immune microenvironment in a large cohort of advanced salivary gland cancer samples. Most tumors exhibit low immune activity with limited immune cell infiltration. Inflammation is linked to higher tumor mutational burden in non-adenoid cystic carcinoma histologies. Subtype specific expression of immune checkpoints is identified with prominent expression of VTCN1 in luminal-like cells within adenoid cystic carcinoma. Macrophages with immunosuppressive properties dominate the immune microenvironment across subtypes. Responses to immunotherapy are limited and associated with a higher ratio of T-cells relative to macrophages in individual cases, warranting further investigation. Here, we show an immunosuppressive environment in salivary gland cancers and identify subtype-specific immune vulnerabilities that could inform tailored therapeutic strategies.

Suggested Citation

  • Erika Zuljan & Benjamin Emde & Iris Piwonski & Ana Pestana & Konrad Klinghammer & Andreas Mock & Peter Horak & Christoph Heining & Frederick Klauschen & Ina Pretzell & Melanie Boerries & Christian H. , 2025. "A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer," Nature Communications, Nature, vol. 16(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60421-0
    DOI: 10.1038/s41467-025-60421-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-60421-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-60421-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Shashank J. Patel & Neville E. Sanjana & Rigel J. Kishton & Arash Eidizadeh & Suman K. Vodnala & Maggie Cam & Jared J. Gartner & Li Jia & Seth M. Steinberg & Tori N. Yamamoto & Anand S. Merchant & Gau, 2017. "Identification of essential genes for cancer immunotherapy," Nature, Nature, vol. 548(7669), pages 537-542, August.
    2. Kosuke Yoshihara & Maria Shahmoradgoli & Emmanuel Martínez & Rahulsimham Vegesna & Hoon Kim & Wandaliz Torres-Garcia & Victor Treviño & Hui Shen & Peter W. Laird & Douglas A. Levine & Scott L. Carter , 2013. "Inferring tumour purity and stromal and immune cell admixture from expression data," Nature Communications, Nature, vol. 4(1), pages 1-11, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zhongqi Fan & Xinchen Zou & Guangyi Wang & Yahui Liu & Yanfang Jiang & Haoyan Wang & Ping Zhang & Feng Wei & Xiaohong Du & Meng Wang & Xiaodong Sun & Bai Ji & Xintong Hu & Liguo Chen & Peiwen Zhou & D, 2024. "A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarker," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    2. Dongliang Bian & Liangdong Sun & Junjie Hu & Liang Duan & Haoran Xia & Xinsheng Zhu & Fenghuan Sun & Lele Zhang & Huansha Yu & Yicheng Xiong & Zhida Huang & Deping Zhao & Nan Song & Jie Yang & Xiao Ba, 2023. "Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    3. Sara Orehek & Taja Železnik Ramuta & Duško Lainšček & Špela Malenšek & Martin Šala & Mojca Benčina & Roman Jerala & Iva Hafner-Bratkovič, 2024. "Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    4. Shaoshuai Tang & Yunzhi Wang & Rongkui Luo & Rundong Fang & Yufeng Liu & Hang Xiang & Peng Ran & Yexin Tong & Mingjun Sun & Subei Tan & Wen Huang & Jie Huang & Jiacheng Lv & Ning Xu & Zhenmei Yao & Qi, 2024. "Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    5. Shiao-Pei Weathers & Xiqi Li & Haifeng Zhu & Ashish V. Damania & Mark Knafl & Brian McKinley & Heather Lin & Rebecca A. Harrison & Nazanin K. Majd & Barbara J. O’Brien & Marta Penas-Prado & Monica Log, 2025. "Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective p," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    6. Nina Frey & Luigi Tortola & David Egli & Sharan Janjuha & Tanja Rothgangl & Kim Fabiano Marquart & Franziska Ampenberger & Manfred Kopf & Gerald Schwank, 2022. "Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    7. Yoshitaka Adachi & Seitaro Terakura & Masahide Osaki & Yusuke Okuno & Yoshitaka Sato & Ken Sagou & Yuki Takeuchi & Hirofumi Yokota & Kanae Imai & Peter Steinberger & Judith Leitner & Ryo Hanajiri & Ma, 2024. "Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    8. Lucia Taraborrelli & Yasin Şenbabaoğlu & Lifen Wang & Junghyun Lim & Kerrigan Blake & Noelyn Kljavin & Sarah Gierke & Alexis Scherl & James Ziai & Erin McNamara & Mark Owyong & Shilpa Rao & Aslihan Ka, 2023. "Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    9. Davide Bernareggi & Qi Xie & Briana C. Prager & Jiyoung Yun & Luisjesus S. Cruz & Timothy V. Pham & William Kim & Xiqing Lee & Michael Coffey & Cristina Zalfa & Pardis Azmoon & Huang Zhu & Pablo Tamay, 2022. "CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    10. Zhengyan Kan & Ji Wen & Vinicius Bonato & Jennifer Webster & Wenjing Yang & Vladimir Ivanov & Kimberly Hyunjung Kim & Whijae Roh & Chaoting Liu & Xinmeng Jasmine Mu & Jennifer Lapira-Miller & Jon Oyer, 2025. "Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors," Nature Communications, Nature, vol. 16(1), pages 1-19, December.
    11. Veronica Rendo & Michael Schubert & Nicholas Khuu & Maria F. Suarez Peredo Rodriguez & Declan Whyte & Xiao Ling & Anouk Brink & Kaimeng Huang & Michelle Swift & Yizhou He & Johanna Zerbib & Ross Smith, 2025. "A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    12. Jennifer G. Abelin & Erik J. Bergstrom & Keith D. Rivera & Hannah B. Taylor & Susan Klaeger & Charles Xu & Eva K. Verzani & C. Jackson White & Hilina B. Woldemichael & Maya Virshup & Meagan E. Olive &, 2023. "Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    13. Boshu Ouyang & Caihua Shan & Shun Shen & Xinnan Dai & Qingwang Chen & Xiaomin Su & Yongbin Cao & Xifeng Qin & Ying He & Siyu Wang & Ruizhe Xu & Ruining Hu & Leming Shi & Tun Lu & Wuli Yang & Shaojun P, 2024. "AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    14. Wanzun Lin & Li Chen & Haojiong Zhang & Xianxin Qiu & Qingting Huang & Fangzhu Wan & Ziyu Le & Shikai Geng & Anlan Zhang & Sufang Qiu & Long Chen & Lin Kong & Jiade J. Lu, 2023. "Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    15. Kang Wang & Ioannis Zerdes & Henrik J. Johansson & Dhifaf Sarhan & Yizhe Sun & Dimitris C. Kanellis & Emmanouil G. Sifakis & Artur Mezheyeuski & Xingrong Liu & Niklas Loman & Ingrid Hedenfalk & Jonas , 2024. "Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    16. Brian D. Lehmann & Antonio Colaprico & Tiago C. Silva & Jianjiao Chen & Hanbing An & Yuguang Ban & Hanchen Huang & Lily Wang & Jamaal L. James & Justin M. Balko & Paula I. Gonzalez-Ericsson & Melinda , 2021. "Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    17. Zaoqu Liu & Yushuai Wu & Hui Xu & Minkai Wang & Siyuan Weng & Dongling Pei & Shuang Chen & WeiWei Wang & Jing Yan & Li Cui & Jingxian Duan & Yuanshen Zhao & Zilong Wang & Zeyu Ma & Ran Li & Wenchao Du, 2025. "Multimodal fusion of radio-pathology and proteogenomics identify integrated glioma subtypes with prognostic and therapeutic opportunities," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    18. Shaoying Zhu & Hui Yang & Jun Liu & Qingsheng Fu & Wei Huang & Qi Chen & Andrew E. Teschendorff & Yungang He & Zhen Yang, 2025. "An improved reference library and method for accurate cell-type deconvolution of bulk-tissue miRNA data," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    19. Michelle G. Webb & Frances Chow & Carmel G. McCullough & Bohan Zhang & John J. Y. Lee & Rania Bassiouni & Norman E. Garrett & Kyle Hurth & John D. Carpten & Gabriel Zada & David W. Craig, 2025. "Resolving spatial subclonal genomic heterogeneity of loss of heterozygosity and extrachromosomal DNA in gliomas," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    20. Hoyeon Jeong & Young-Rae Cho & Jungsoo Gim & Seung-Kuy Cha & Maengsup Kim & Dae Ryong Kang, 2024. "GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure," PLOS ONE, Public Library of Science, vol. 19(3), pages 1-18, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60421-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.